Target intelligence / Profile preview

Meiotic recombination protein REC8 homolog (REC8)

Target
REC8
Molecular classification
Kleisin family protein, Structural maintenance of chromosome (SMC) complex partner, Cohesin complex component, Chromosome-associated protein
01

Overview

Meiotic recombination protein REC8 homolog (REC8) is a meiosis-specific component of the cohesin complex, encoded by the human REC8 gene. It binds sister chromatids and is essential for their cohesion during both divisions of meiosis[1]. REC8 localizes to chromosome axes during meiosis, forming structural scaffolds necessary for the synaptonemal complex and proper homologous recombination[3]. Its removal from chromosome arms in meiosis I enables homologous chromosomes to separate, while retention at centromeres maintains sister chromatid cohesion until anaphase II[1]. REC8 partners with other cohesin proteins (STAG3, SMC1B, SMC3) to regulate chromatid cohesion and recombination. Disruption leads to improper chromosome pairing, meiotic errors, and sterility[3]. REC8 is not a therapeutic target (such as a receptor, enzyme, or transporter), but is fundamental for meiotic chromosome dynamics and fertility[1][3][4].

Other names
HR21SPBREC8PREC8L1Rec8pkleisin-alphacohesin Rec8phuman homolog of rad21meiotic recombination protein REC8-like 1cohesion rec8pS. pombe Rec8meiotic recombination and sister chromatid cohesion phosphoprotein of the rad21p familyrecombination and sister chromatid cohesion protein homolog
02

Mechanism of action

null

03

Biological functions

Sister chromatid cohesion during meiosisHomologous recombinationSynaptonemal complex formationChromosome segregation in meiosisAssembly of meiosis-specific chromatin loopsScaffold for linear element (LinE) assembly in synaptonemal complex
04

Disease associations

Germ cell failureSterility (male and female)Meiotic defects (chromosome missegregation)Possibly developmental anomalies (as null mice show failure to thrive)
05

Safety considerations

Loss-of-function can cause infertility (germ cell failure and meiotic disruption)Potential risks from complete inhibition include defective gametogenesis and sterility

Beyond the preview

Go deeper on Meiotic recombination protein REC8 homolog (REC8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Meiotic recombination protein REC8 homolog (REC8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call